- Report
- October 2025
- 22 Pages
Ireland
From €995EUR$1,188USD£904GBP
- Report
- October 2025
- 26 Pages
South Africa
From €995EUR$1,188USD£904GBP
- Report
- October 2025
- 22 Pages
North Macedonia
From €995EUR$1,188USD£904GBP
- Report
- October 2025
- 26 Pages
China, Hong Kong
From €995EUR$1,188USD£904GBP
- Report
- October 2025
- 22 Pages
Indonesia
From €995EUR$1,188USD£904GBP
- Report
- October 2025
- 25 Pages
Thailand
From €995EUR$1,188USD£904GBP
- Report
- October 2025
- 21 Pages
Uzbekistan
From €995EUR$1,188USD£904GBP
- Report
- October 2025
- 24 Pages
Greece
From €995EUR$1,188USD£904GBP
- Report
- October 2025
- 22 Pages
Portugal
From €995EUR$1,188USD£904GBP
- Report
- October 2025
- 26 Pages
Malaysia
From €995EUR$1,188USD£904GBP
- Report
- October 2025
- 21 Pages
Denmark
From €995EUR$1,188USD£904GBP
- Report
- October 2025
- 21 Pages
Uruguay
From €995EUR$1,188USD£904GBP
- Report
- October 2025
- 23 Pages
Slovakia
From €995EUR$1,188USD£904GBP
- Report
- October 2025
- 21 Pages
Slovenia
From €995EUR$1,188USD£904GBP
- Report
- October 2025
- 21 Pages
Sweden
From €995EUR$1,188USD£904GBP
- Report
- October 2025
- 22 Pages
Israel
From €995EUR$1,188USD£904GBP
- Report
- October 2025
- 21 Pages
Latvia
From €995EUR$1,188USD£904GBP
- Report
- October 2025
- 24 Pages
Peru
From €995EUR$1,188USD£904GBP
- Report
- October 2025
- 23 Pages
Romania
From €995EUR$1,188USD£904GBP
- Report
- October 2025
- 22 Pages
Netherlands
From €995EUR$1,188USD£904GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more